166 results on '"Quintin-Roué, Isabelle"'
Search Results
2. Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing
3. Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation
4. Progressive multifocal leukoencephalopathy in patients with chronic liver disease successfully treated with pembrolizumab
5. HER2 Mutated and Nonmutated Non–small Cell Lung Carcinomas Can Harbor Heterogeneous HER2 Gene Amplification and HER2 Protein Expression
6. Ramp Lesions of the Posterior Segment of the Medial Meniscus: What Is Repaired? A Qualitative Histological Study of the Meniscocapsular and Meniscotibial Attachments
7. EPR17341 and A7H6R pan-TRK Immunohistochemistry Result in Highly Different Staining Patterns in a Series of Salivary Gland Tumors
8. PD-L1 Immunohistochemistry-Discrepant Results Between Synchronous Tumor Samples May Cause More Treatment Choice Dilemmas Than Molecular Heterogeneity in Patients With Advanced Non–Small Cell Lung Cancers
9. Screening for NTRK-rearranged Tumors Using Immunohistochemistry: Comparison of 2 Different pan-TRK Clones in Melanoma Samples
10. Combining ALK Fluorescent In Situ Hybridization and Immunohistochemistry to Analyze Multiple Non–Small Cell Lung Carcinoma Samples per Patient Reveals Intermethod and Intersample-discrepant Results
11. Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists?
12. False ALK Rearrangement Signals in Inflammatory Cells: A Pitfall in the Interpretation of ALK Fluorescence In Situ Hybridization in Non–Small Cell Lung Cancer
13. Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co‐deleted anaplastic gliomas
14. Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell Lymphoma
15. Extinction of myeloproliferative neoplasm by acquisition of a lymphoid disease: JAK2 V617F and JAK2 exon 12 allele burden disappearance during the follow-up of two patients
16. About MET expression and other biomarkers in non-small cell lung cancer
17. Prognostic Relevance of Histomolecular Classification of Diffuse Adult High-Grade Gliomas with Necrosis
18. Reliability of histopathological salivary gland biopsy assessment in Sjögren’s syndrome: a multicentre cohort study
19. Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing
20. Identification of a novel population in high-grade oligodendroglial tumors not deleted on 1p/19q using array CGH
21. Transformation d’un mélanocytome méningé en mélanome : étude clinique, histopathologique et cytogénétique
22. An atypical lower limb pain revealing a possible systemic venous vasculitis
23. Tri-lineage disease involving sideroblastic anaemia, multiple myeloma and B-cell non-Hodgkinʼs lymphoma in the same patient
24. Establishment of a novel human B-CLL-like xenograft model in nude mouse
25. A Mismatch Repair–Deficient Hepatoid Adenocarcinoma of the Lung Responding to Anti–PD-L1 Durvalumab Therapy Despite no PD-L1 Expression
26. [Meningeal melanoma arising from a preexisting meningeal melanocytoma: A clinical, pathological and cytogenetic study about one case]
27. Sequential mutational evaluation of CALR ‐mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression
28. PD-L1 Immunohistochemistry-Discrepant Results Between Synchronous Tumor Samples May Cause More Treatment Choice Dilemmas Than Molecular Heterogeneity in Patients With Advanced Non–Small Cell Lung Cancers
29. About concomitant KRAS and other molecular alterations in non–small cell lung cancers
30. Screening for NTRK-rearranged Tumors Using Immunohistochemistry: Comparison of 2 Different pan-TRK Clones in Melanoma Samples
31. Acute dyspnoea and single tracheal localisation of mantle cell lymphoma
32. Detection of NTRKfusions in glioblastoma: fluorescent in situhybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing
33. An atypical lower limb pain revealing a possible systemic venous vasculitis.
34. Sequential mutational evaluation of CALR ‐mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression.
35. Outcome of Ph negative myeloproliferative neoplasms transforming to accelerated or leukemic phase
36. Increasing of HER2 membranar density in human glioblastoma U251MG cell line established in a new nude mice model
37. Mitotic index, microvascular proliferation, and necrosis define 3 pathological subgroups of prognostic relevance among 1p/19q co-deleted anaplastic oligodendrogliomas
38. Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network
39. The presence of monoclonal gammopathy in Ph-negative myeloproliferative neoplasms is associated with a detrimental effect on outcomes
40. Increasing of HER2 Membranar Density in Human Glioblastoma U251MG Cell Line Established in a New Nude Mice Model
41. Les « ramp lesions » du segment postérieur du ménisque médial : que répare t-on ? Étude anatomique et histologique
42. Evaluation of a fast and fully automated platform to diagnoseEGFRandKRASmutations in formalin-fixed and paraffin-embedded non-small cell lung cancer samples in less than one day
43. ALK ambiguous-positive non-small cell lung cancers are tumors challenged by diagnostic and therapeutic issues
44. Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer
45. Combining ALKFluorescent In Situ Hybridization and Immunohistochemistry to Analyze Multiple Non–Small Cell Lung Carcinoma Samples per Patient Reveals Intermethod and Intersample-discrepant Results
46. Un mélanome de progression insidieuse et rapidement fatale chez une adolescente
47. Diagnostic value of labial minor salivary gland biopsy for primary Sjögren's syndrome: a systematic review
48. HER2Mutated and Nonmutated Non–small Cell Lung Carcinomas Can Harbor Heterogeneous HER2Gene Amplification and HER2 Protein Expression
49. Mitral and aortic valvular disease associated with benfluorex use
50. B-cell and T-cell quantification in minor salivary glands in primary Sjögren’s syndrome: development and validation of a pixel-based digital procedure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.